Exercise of Options

RNS Number : 3941F

Hutchison China Meditech Limited

14 June 2012

 



Hutchison China MediTech Limited ("Chi-Med")

(AIM: HCM)

Exercise of Options

London: Thursday, 14 June 2012: Chi-Med announces that it has issued 192,108 ordinary shares of US$1.00 each (the "Shares") following the exercise of options by Mr Johnny Cheng, Executive Director and Chief Financial Officer of Chi-Med, at an exercise price of GBP1.26 per share on 14 June 2012. 

Following the issue of the Shares, Mr Cheng is beneficially interested in 192,108 Shares, representing approximately 0.37% of the current issued share capital of Chi-Med.

Ends

Enquiries

Chi-Med Christian Hogg, CEO	Telephone:      [phone]
Citigate Dewe Rogerson Anthony Carlisle David Dible	Telephone:      [phone] Mobile:             [phone] Mobile:             [phone]
Lazard & Co., Limited Paul Gismondi Nick Fowler	Telephone:      [phone]

About Chi-Med

Chi-Med is the holding company of a healthcare group based primarily in China and was listed on the Alternative Investment Market of the London Stock Exchange in May 2006.  It is focused on researching, developing, manufacturing and selling pharmaceuticals and health oriented consumer products.

Chi-Med is majority owned by Hutchison Whampoa Limited, an international company listed on the Main Board of The Stock Exchange of Hong Kong Limited.

 

END

 

 

MSCEAAKLFDAAEFF